331 related articles for article (PubMed ID: 26841933)
21. MLL2 mutation detection in 86 patients with Kabuki syndrome: a genotype-phenotype study.
Makrythanasis P; van Bon BW; Steehouwer M; Rodríguez-Santiago B; Simpson M; Dias P; Anderlid BM; Arts P; Bhat M; Augello B; Biamino E; Bongers EM; Del Campo M; Cordeiro I; Cueto-González AM; Cuscó I; Deshpande C; Frysira E; Izatt L; Flores R; Galán E; Gener B; Gilissen C; Granneman SM; Hoyer J; Yntema HG; Kets CM; Koolen DA; Marcelis Cl; Medeira A; Micale L; Mohammed S; de Munnik SA; Nordgren A; Psoni S; Reardon W; Revencu N; Roscioli T; Ruiterkamp-Versteeg M; Santos HG; Schoumans J; Schuurs-Hoeijmakers JH; Silengo MC; Toledo L; Vendrell T; van der Burgt I; van Lier B; Zweier C; Reymond A; Trembath RC; Perez-Jurado L; Dupont J; de Vries BB; Brunner HG; Veltman JA; Merla G; Antonarakis SE; Hoischen A
Clin Genet; 2013 Dec; 84(6):539-45. PubMed ID: 23320472
[TBL] [Abstract][Full Text] [Related]
22. Recurrent giant cell fibroblastoma: Malignancy predisposition in Kabuki syndrome revisited.
Karagianni P; Lambropoulos V; Stergidou D; Fryssira H; Chatziioannidis I; Spyridakis I
Am J Med Genet A; 2016 May; 170A(5):1333-8. PubMed ID: 26898171
[TBL] [Abstract][Full Text] [Related]
23. Unraveling molecular pathways shared by Kabuki and Kabuki-like syndromes.
Lintas C; Persico AM
Clin Genet; 2018 Oct; 94(3-4):283-295. PubMed ID: 28139835
[TBL] [Abstract][Full Text] [Related]
24. Update of the genotype and phenotype of KMT2D and KDM6A by genetic screening of 100 patients with clinically suspected Kabuki syndrome.
Murakami H; Tsurusaki Y; Enomoto K; Kuroda Y; Yokoi T; Furuya N; Yoshihashi H; Minatogawa M; Abe-Hatano C; Ohashi I; Nishimura N; Kumaki T; Enomoto Y; Naruto T; Iwasaki F; Harada N; Ishikawa A; Kawame H; Sameshima K; Yamaguchi Y; Kobayashi M; Tominaga M; Ishikiriyama S; Tanaka T; Suzumura H; Ninomiya S; Kondo A; Kaname T; Kosaki K; Masuno M; Kuroki Y; Kurosawa K
Am J Med Genet A; 2020 Oct; 182(10):2333-2344. PubMed ID: 32803813
[TBL] [Abstract][Full Text] [Related]
25. The defining DNA methylation signature of Kabuki syndrome enables functional assessment of genetic variants of unknown clinical significance.
Aref-Eshghi E; Schenkel LC; Lin H; Skinner C; Ainsworth P; Paré G; Rodenhiser D; Schwartz C; Sadikovic B
Epigenetics; 2017; 12(11):923-933. PubMed ID: 28933623
[TBL] [Abstract][Full Text] [Related]
26. Growth charts in Kabuki syndrome 1.
Ruault V; Corsini C; Duflos C; Akouete S; Georgescu V; Abaji M; Alembick Y; Alix E; Amiel J; Amouroux C; Barat-Houari M; Baumann C; Bonnard A; Boursier G; Boute O; Burglen L; Busa T; Cordier MP; Cormier-Daire V; Delrue MA; Doray B; Faivre L; Fradin M; Gilbert-Dussardier B; Giuliano F; Goldenberg A; Gorokhova S; Héron D; Isidor B; Jacquemont ML; Jacquette A; Jeandel C; Lacombe D; Le Merrer M; Sang KHLQ; Lyonnet S; Manouvrier S; Michot C; Moncla A; Moutton S; Odent S; Pelet A; Philip N; Pinson L; Reversat J; Roume J; Sanchez E; Sanlaville D; Sarda P; Schaefer E; Till M; Touitou I; Toutain A; Willems M; Gatinois V; Geneviève D
Am J Med Genet A; 2020 Mar; 182(3):446-453. PubMed ID: 31876365
[TBL] [Abstract][Full Text] [Related]
27. Kabuki syndrome as a cause of non-immune fetal hydrops/ascites.
Long A; Sinkovskaya ES; Edmondson AC; Zackai E; Schrier Vergano SA
Am J Med Genet A; 2016 Dec; 170(12):3333-3337. PubMed ID: 27568880
[TBL] [Abstract][Full Text] [Related]
28. Hypermobility in individuals with Kabuki syndrome: The effect of growth hormone treatment.
Schott DA; Stumpel CTRM; Klaassens M
Am J Med Genet A; 2019 Feb; 179(2):219-223. PubMed ID: 30556359
[TBL] [Abstract][Full Text] [Related]
29. Prenatal and perinatal history in Kabuki Syndrome.
Rosenberg CE; Daly T; Hung C; Hsueh I; Lindsley AW; Bodamer O
Am J Med Genet A; 2020 Jan; 182(1):85-92. PubMed ID: 31654559
[TBL] [Abstract][Full Text] [Related]
30. Autism spectrum disorder in Kabuki syndrome: clinical, diagnostic and rehabilitative aspects assessed through the presentation of three cases.
Parisi L; Di Filippo T; Roccella M
Minerva Pediatr; 2015 Aug; 67(4):369-75. PubMed ID: 26129805
[TBL] [Abstract][Full Text] [Related]
31. The phenotypic spectrum of Kabuki syndrome in patients of Chinese descent: A case series.
Wang Y; Li N; Su Z; Xu Y; Liu S; Chen Y; Li X; Shen Y; Hung C; Wang J; Wang X; Bodamer O
Am J Med Genet A; 2020 Apr; 182(4):640-651. PubMed ID: 31883305
[TBL] [Abstract][Full Text] [Related]
32. Investigation of genetic and phenotypic heterogeneity in 37 Turkish patients with Kabuki and Kabuki-like phenotype.
Usluer E; Sayın GY; Güneş N; Kasap B; Tüysüz B
Am J Med Genet A; 2022 Oct; 188(10):2976-2987. PubMed ID: 36097644
[TBL] [Abstract][Full Text] [Related]
33. A three generation X-linked family with Kabuki syndrome phenotype and a frameshift mutation in KDM6A.
Lederer D; Shears D; Benoit V; Verellen-Dumoulin C; Maystadt I
Am J Med Genet A; 2014 May; 164A(5):1289-92. PubMed ID: 24664873
[TBL] [Abstract][Full Text] [Related]
34. [One novel pathologic variation in
Qiu SW; Yuan YY
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Sep; 33(9):820-824. PubMed ID: 31446696
[No Abstract] [Full Text] [Related]
35. Kabuki syndrome: novel pathogenic variants, new phenotypes and review of literature.
Shangguan H; Su C; Ouyang Q; Cao B; Wang J; Gong C; Chen R
Orphanet J Rare Dis; 2019 Nov; 14(1):255. PubMed ID: 31727177
[TBL] [Abstract][Full Text] [Related]
36. De novo exonic deletion of KDM6A in a Chinese girl with Kabuki syndrome: A case report and brief literature review.
Yang P; Tan H; Xia Y; Yu Q; Wei X; Guo R; Peng Y; Chen C; Li H; Mei L; Huang Y; Liang D; Wu L
Am J Med Genet A; 2016 Jun; 170(6):1613-21. PubMed ID: 27028180
[TBL] [Abstract][Full Text] [Related]
37. Defects of B-cell terminal differentiation in patients with type-1 Kabuki syndrome.
Lindsley AW; Saal HM; Burrow TA; Hopkin RJ; Shchelochkov O; Khandelwal P; Xie C; Bleesing J; Filipovich L; Risma K; Assa'ad AH; Roehrs PA; Bernstein JA
J Allergy Clin Immunol; 2016 Jan; 137(1):179-187.e10. PubMed ID: 26194542
[TBL] [Abstract][Full Text] [Related]
38. Neuroimaging in Kabuki syndrome and another KMT2D-related disorder.
Stadelmaier RT; Kenna MA; Barrett D; Mullen TE; Bodamer O; Agrawal PB; Robson CD; Wojcik MH
Am J Med Genet A; 2021 Dec; 185(12):3770-3783. PubMed ID: 34369642
[TBL] [Abstract][Full Text] [Related]
39. RAP1-mediated MEK/ERK pathway defects in Kabuki syndrome.
Bögershausen N; Tsai IC; Pohl E; Kiper PÖ; Beleggia F; Percin EF; Keupp K; Matchan A; Milz E; Alanay Y; Kayserili H; Liu Y; Banka S; Kranz A; Zenker M; Wieczorek D; Elcioglu N; Prontera P; Lyonnet S; Meitinger T; Stewart AF; Donnai D; Strom TM; Boduroglu K; Yigit G; Li Y; Katsanis N; Wollnik B
J Clin Invest; 2015 Sep; 125(9):3585-99. PubMed ID: 26280580
[TBL] [Abstract][Full Text] [Related]
40. On the significance of craniosynostosis in a case of Kabuki syndrome with a concomitant KMT2D mutation and 3.2 Mbp de novo 10q22.3q23.1 deletion.
Topa A; Samuelsson L; Lovmar L; Stenman G; Kölby L
Am J Med Genet A; 2017 Aug; 173(8):2219-2225. PubMed ID: 28590022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]